• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亨廷顿病:表型和基因型的新方面。

Huntington's disease: new aspects on phenotype and genotype.

机构信息

Department of Neurology, West China Hospital, Sichuan University, Sichuan, PR China.

出版信息

Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S107-9. doi: 10.1016/S1353-8020(11)70034-7.

DOI:10.1016/S1353-8020(11)70034-7
PMID:22166403
Abstract

Huntington's disease typically presents with involuntary movements, cognitive decline and behavioural abnormalities; however, new data show a greater spectrum and more complexity in the mode of presentation than previously appreciated. On one hand efforts are under way to better assess all aspects of the evolving phenotype over the course of the disease, on the other hand large cohorts have been prospectively followed-up and similar efforts are now being started in China. In this communication, we briefly review the most salient findings from the last couple of years. The recently established large cohorts allow the performance of accurate studies examining correlation of genetic polymorphisms with specific aspects of the phenotype thus allowing for some mechanistic insight into the causes of phenotypic variation. While Huntington's disease is the most frequent hereditary cause of chorea, other disorders with similar clinical phenotypes, including neuroacanthocytosis, are now better known, including a better understanding of the primary cause as well as the pathophysiology at the molecular level. Studies on the mechanisms of disease in these different disorders may shed light on the respective pathomechanisms and may open new approaches to a better understanding and additional treatment options for choreatiform neurodegenerative disorders.

摘要

亨廷顿病通常表现为不自主运动、认知能力下降和行为异常;然而,新的数据显示,在发病模式方面,其表现形式比以前所认识的更加广泛和复杂。一方面,人们正在努力更好地评估疾病过程中不断发展的表型的所有方面,另一方面,已经对大量队列进行了前瞻性随访,目前在中国也正在开展类似的工作。在本通讯中,我们简要回顾了过去几年中最显著的发现。最近建立的大型队列允许进行准确的研究,检查遗传多态性与表型特定方面的相关性,从而为表型变异的原因提供一些机制上的见解。虽然亨廷顿病是舞蹈病最常见的遗传性病因,但其他具有类似临床表型的疾病,包括神经棘红细胞增多症,现在也更为人所知,包括对主要病因以及分子水平的病理生理学有了更好的理解。对这些不同疾病中疾病机制的研究可能会揭示各自的发病机制,并为更好地理解和增加舞蹈病性神经退行性疾病的治疗选择开辟新途径。

相似文献

1
Huntington's disease: new aspects on phenotype and genotype.亨廷顿病:表型和基因型的新方面。
Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S107-9. doi: 10.1016/S1353-8020(11)70034-7.
2
Huntington's disease phenocopy syndromes.亨廷顿病表型模拟综合征
Curr Opin Neurol. 2007 Dec;20(6):681-7. doi: 10.1097/WCO.0b013e3282f12074.
3
Huntington's disease in Thailand: a case report.泰国的亨廷顿舞蹈症:一例病例报告。
J Med Assoc Thai. 1992 Feb;75(2):123-6.
4
A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion.一种与亨廷顿舞蹈症相似的疾病与一种新的CAG重复序列扩增有关。
Ann Neurol. 2001 Sep;50(3):373-80.
5
Huntington's disease and Huntington's disease-like syndromes: an overview.亨廷顿病和亨廷顿病样综合征:概述。
Curr Opin Neurol. 2013 Aug;26(4):420-7. doi: 10.1097/WCO.0b013e3283632d90.
6
The Huntington's disease-like syndromes: what to consider in patients with a negative Huntington's disease gene test.亨廷顿病样综合征:亨廷顿病基因检测呈阴性的患者应考虑哪些因素。
Nat Clin Pract Neurol. 2007 Sep;3(9):517-25. doi: 10.1038/ncpneuro0606.
7
Genetics of Huntington's disease and related disorders.亨廷顿舞蹈症及相关疾病的遗传学
Drug Discov Today. 2014 Jul;19(7):985-9. doi: 10.1016/j.drudis.2014.03.005. Epub 2014 Mar 18.
8
[Genetics in movement disorders--dystonia, tremor and chorea].[运动障碍中的遗传学——肌张力障碍、震颤和舞蹈病]
Tidsskr Nor Laegeforen. 2004 Sep 9;124(17):2236-7.
9
[The characteristics of the familial polymorphism of Huntington's chorea].[亨廷顿舞蹈病的家族性多态性特征]
Zh Nevropatol Psikhiatr Im S S Korsakova. 1991;91(11):59-64.
10
[Chorea and Huntington's disease].[舞蹈病与亨廷顿舞蹈症]
Rev Prat. 1997 May 15;47(10):1083-7.

引用本文的文献

1
A Glimpse of Molecular Biomarkers in Huntington's Disease.亨廷顿病的分子生物标志物概述。
Int J Mol Sci. 2022 May 12;23(10):5411. doi: 10.3390/ijms23105411.
2
Transcriptional correlates of the pathological phenotype in a Huntington's disease mouse model.亨廷顿病小鼠模型病理表型的转录相关性。
Sci Rep. 2019 Dec 10;9(1):18696. doi: 10.1038/s41598-019-55177-9.
3
Transcription, epigenetics and ameliorative strategies in Huntington's Disease: a genome-wide perspective.亨廷顿舞蹈症中的转录、表观遗传学及改善策略:全基因组视角
Mol Neurobiol. 2015 Feb;51(1):406-23. doi: 10.1007/s12035-014-8715-8. Epub 2014 May 1.
4
Phosphorylation of mutant huntingtin at serine 116 modulates neuronal toxicity.突变型亨廷顿蛋白在丝氨酸116位点的磷酸化调节神经元毒性。
PLoS One. 2014 Feb 5;9(2):e88284. doi: 10.1371/journal.pone.0088284. eCollection 2014.